Scientific EXPERT Act of 2025
3/17/2025, 3:58 PMSummary of Bill HR 1532
Bill 119 HR 1532, also known as the External Drug Development Meetings Act, aims to amend the Federal Food, Drug, and Cosmetic Act to create a structured process for holding science-focused drug development meetings. These meetings would be led by external experts in the field, rather than solely by the Food and Drug Administration (FDA).The purpose of these meetings is to enhance the drug development process by bringing together a diverse group of stakeholders, including researchers, clinicians, patients, and industry representatives, to discuss and provide input on potential new drugs. By involving external experts in the decision-making process, the bill aims to improve the efficiency and effectiveness of drug development, ultimately leading to better and more innovative treatments for patients.
In addition to establishing a process for these externally led meetings, the bill also includes provisions for ensuring transparency and accountability in the drug development process. This includes requirements for public disclosure of meeting summaries and recommendations, as well as guidelines for managing conflicts of interest among meeting participants. Overall, Bill 119 HR 1532 seeks to promote collaboration and innovation in drug development by involving a broader range of stakeholders in the decision-making process. By fostering a more inclusive and transparent approach to drug development, the bill aims to improve the quality and availability of new treatments for patients.
Read the Full Bill
Current Status of Bill HR 1532
Bill HR 1532 is currently in the status of Bill Introduced since February 24, 2025. Bill HR 1532 was introduced during Congress 119 and was introduced to the House on February 24, 2025. Bill HR 1532's most recent activity was Referred to the House Committee on Energy and Commerce. as of February 24, 2025Bipartisan Support of Bill HR 1532
Total Number of Sponsors
3Democrat Sponsors
3Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
0Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 1532
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 1532
To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.Comments
Most relevant
Sponsors and Cosponsors of HR 1532
Latest Bills
Stop Raising Prices on Food Act
Bill HR 2842April 26, 2025
Protecting Medical Research Funding Act
Bill HR 2855April 26, 2025
Youth Sports Facilities Act of 2025
Bill HR 2850April 26, 2025
Housing Supply Frameworks Act
Bill HR 2840April 26, 2025
Reconciliation in Place Names Act
Bill HR 2843April 26, 2025
Great Lakes and National Weather Service Funding Protection Act
Bill HR 2856April 26, 2025
Expanded Student Saver’s Tax Credit Act
Bill HR 2852April 26, 2025
Drain the Swamp Act
Bill HR 2857April 26, 2025
Stop Arctic Ocean Drilling Act of 2025
Bill HR 2848April 26, 2025
Michael Enzi Voluntary Protection Program Act
Bill HR 2844April 26, 2025